Blocking renin-angiotensin system (RAAS) with an inhibitor of angiotensin converting enzyme (ACE) reduced IL-6 and inflammation markers in atherosclerosis experimental model (Tikellis et al., 2012). The gene discussed is IL6; the disease is atherosclerosis.